| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 130.31B | 131.03B | 124.32B | 113.50B | 107.96B | 96.89B |
| Gross Profit | 19.74B | 19.85B | 18.80B | 17.50B | 16.35B | 14.95B |
| EBITDA | 8.05B | 6.86B | 7.21B | 6.01B | 5.61B | 4.93B |
| Net Income | 5.33B | 5.02B | 4.69B | 4.00B | 3.67B | 3.18B |
Balance Sheet | ||||||
| Total Assets | 96.66B | 100.06B | 100.67B | 94.76B | 84.47B | 76.77B |
| Cash, Cash Equivalents and Short-Term Investments | 29.20B | 24.10B | 28.95B | 26.86B | 22.93B | 17.60B |
| Total Debt | 251.00M | 0.00 | 80.00M | 32.00M | 20.00M | 40.00M |
| Total Liabilities | 52.51B | 49.86B | 56.65B | 54.38B | 50.43B | 46.01B |
| Stockholders Equity | 43.90B | 49.92B | 43.74B | 40.13B | 33.81B | 30.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.90B | 3.18B | 4.51B | 6.35B | 6.46B |
| Operating Cash Flow | 0.00 | -3.55B | 3.59B | 5.01B | 6.72B | 6.57B |
| Investing Cash Flow | 0.00 | 250.00M | 461.00M | -69.00M | -461.00M | -152.00M |
| Financing Cash Flow | 0.00 | -1.63B | -2.05B | -1.08B | -971.00M | -808.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥43.81B | 9.16 | ― | 3.87% | 1.79% | -12.61% | |
77 Outperform | ¥308.80B | 21.45 | ― | 1.68% | 8.46% | 26.64% | |
73 Outperform | ¥52.36B | 9.93 | ― | 3.00% | 5.40% | 8.39% | |
73 Outperform | ¥154.63B | 9.94 | ― | 1.72% | 46.71% | 77.52% | |
65 Neutral | ¥28.13B | 14.13 | ― | 2.98% | 2.25% | 40.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥146.79B | 9.32 | ― | 2.42% | 8.46% | -3.62% |